Adams Asset Advisors, LLC Amgen Inc Transaction History

Adams Asset Advisors, LLC

$645 Million
Q3 2024

A detailed history of Adams Asset Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Adams Asset Advisors, LLC holds 39,655 shares of AMGN stock, worth $11.7 Million. This represents 1.98% of its overall portfolio holdings.

Number of Shares

39,655

Previous 40,049 0.98%

Holding current value

$11.7 Million

Previous $12.5 Million 2.11%

% of portfolio

1.98%

Previous 1.68%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$309.38 - $337.38 $121,895 - $132,927	-394 Reduced 0.98%	39,655 $12.8 Million
Q1 2024 Apr 09, 2024	SELL	$268.87 - $324.56 $86,307 - $104,183	-321 Reduced 0.8%	40,049 $11.4 Million
Q4 2023 Jan 12, 2024	SELL	$255.7 - $288.46 $200,213 - $225,864	-783 Reduced 1.9%	40,370 $11.6 Million
Q3 2023 Oct 11, 2023	BUY	$218.65 - $271.46 $602,818 - $748,415	2,757 Added 7.18%	41,153 $11.1 Million
Q2 2023 Jul 14, 2023	SELL	$214.27 - $253.37 $1.64 Million - $1.94 Million	-7,645 Reduced 16.6%	38,396 $8.52 Million
Q1 2023 Apr 12, 2023	BUY	$225.79 - $275.2 $27,997 - $34,124	124 Added 0.27%	46,041 $11.1 Million
Q4 2022 Jan 13, 2023	SELL	$229.03 - $291.01 $88,634 - $112,620	-387 Reduced 0.84%	45,917 $0
Q3 2022 Oct 12, 2022	BUY	$224.46 - $253.15 $48,258 - $54,427	215 Added 0.47%	46,304 $10.4 Million
Q2 2022 Jul 13, 2022	BUY	$230.71 - $256.74 $1.17 Million - $1.3 Million	5,054 Added 12.32%	46,089 $11.2 Million
Q1 2022 Apr 20, 2022	BUY	$219.27 - $242.57 $778,408 - $861,123	3,550 Added 9.47%	41,035 $9.92 Million
Q4 2021 Jan 12, 2022	BUY	$198.88 - $227.6 $595,048 - $680,979	2,992 Added 8.67%	37,485 $8.43 Million
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $317,980 - $372,552	1,498 Added 4.54%	34,493 $7.33 Million
Q2 2021 Jul 14, 2021	BUY	$233.58 - $259.14 $2.13 Million - $2.37 Million	9,129 Added 38.25%	32,995 $8.04 Million
Q1 2021 Apr 12, 2021	BUY	$221.91 - $258.6 $105,407 - $122,835	475 Added 2.03%	23,866 $5.94 Million
Q4 2020 Jan 22, 2021	BUY	$216.38 - $257.67 $113,815 - $135,534	526 Added 2.3%	23,391 $5.38 Million
Q3 2020 Oct 16, 2020	BUY	$234.65 - $260.95 $43,175 - $48,014	184 Added 0.81%	22,865 $5.81 Million
Q2 2020 Jul 21, 2020	BUY	$197.81 - $242.74 $66,266 - $81,317	335 Added 1.5%	22,681 $5.35 Million
Q1 2020 Apr 20, 2020	BUY	$182.24 - $241.7 $672,465 - $891,873	3,690 Added 19.78%	22,346 $4.53 Million
Q1 2020 Apr 20, 2020	SELL	$182.24 - $241.7 $672,465 - $891,873	-3,690 Reduced 16.51%	18,656 $3.78 Million
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $361,012 - $464,025	1,908 Added 9.34%	22,346 $5.39 Million
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $177,243 - $212,375	1,018 Added 5.24%	20,438 $395,000
Q2 2019 Jul 12, 2019	BUY	$166.7 - $195.41 $3.24 Million - $3.79 Million	19,420 New	19,420 $3.58 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adams Asset Advisors, LLC with notifications on news.

Account

Adams Asset Advisors, LLC Amgen Inc Transaction History